Recruiting PHASE4 INTERVENTIONAL 2-arm NCT05076110

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Sponsor: Mayo Clinic

Interventions Acetaminophen Gabapentin Ibuprofen Methocarbamol Oxycodone

Updated 8 times since 2021 Last updated: May 30, 2025 Started: Apr 7, 2022 Primary completion: Mar 31, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05076110, this PHASE4 trial focuses on Hip Arthroscopy and remains actively recruiting participants. Sponsored by Mayo Clinic, it has been updated 8 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jul 2025 — Present [monthly]

Recruiting PHASE4
Sep 2024 — Jul 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jun 2023 — Jul 2024 [monthly]

Recruiting PHASE4
Jun 2022 — Jun 2023 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting

▶ Show 3 earlier versions

Mar 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE4
Dec 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE4
Nov 2021 — Dec 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States